Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15466445 | 1.00 | ALDH1A1 (0.40) | ALDH1A1GAATDP1ATMCYP19A1 | |
| SCHEMBL7365903 | 0.78 | ATM (0.44) | ATMCYP19A1 | |
| SCHEMBL15467671 | 0.73 | ALDH1A1 (0.40) | ALDH1A1GAATDP1CYP19A1EPHX2 | |
| SCHEMBL3870190 | 0.71 | ATM (0.43) | ALDH1A1GAATDP1ATMCYP19A1 | |
| SCHEMBL1088861 | 0.71 | ALDH1A1 (0.38) | ALDH1A1GAATDP1ATMCYP19A1 | |
| SCHEMBL22263961 | 0.69 | — | — | |
| SCHEMBL1089298 | 0.68 | ALDH1A1 (0.41) | ALDH1A1GAATDP1CYP19A1EPHX2 | |
| SCHEMBL22263779 | 0.68 | — | — | |
| SCHEMBL22263880 | 0.68 | — | — | |
| SCHEMBL15466872 | 0.68 | ALDH1A1 (0.43) | ALDH1A1GAATDP1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10227433-B2 | Cycloalkylnorbornene monomers, polymers derived therefrom and their use in pervaporation | PROMERUS, LLC (US) | 2019-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10227433-B2 | Cycloalkylnorbornene monomers, polymers derived therefrom and their use in pervaporation | NOTUM, AGPS, WEE1 | ALDH1A1 3394/4885GAA 2851/4885TDP1 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.